Pharmacological evaluation of a new Ca2+ antagonist, 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate hydrochloride (TMB-8): studies in smooth muscles.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D001464:Barium / Q000037:antagonists & inhibitors; D001667:Binding, Competitive; D002118:Calcium / Q000037:antagonists & inhibitors*; D004048:Diethylamines / Q000494:pharmacology; D004246:Dimethylphenylpiperazinium Iodide / Q000037:antagonists & inhibitors; D004305:Dose-Response Relationship, Drug; D005260:Female; D005707:Gallic Acid / Q000494:pharmacology* / Q000031:analogs & derivatives; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D009538:Nicotine / Q000037:antagonists & inhibitors; D010275:Parasympathetic Nervous System / Q000187:drug effects; D010477:Perfusion; D011189:Potassium Chloride / Q000037:antagonists & inhibitors; D009435:Synaptic Transmission / Q000187:drug effects; D013997:Time Factors; D014649:Vas Deferens / Q000187:drug effects
D004048:Diethylamines; D001464:Barium; D004246:Dimethylphenylpiperazinium Iodide; C006014:8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate; D005707:Gallic Acid; D011189:Potassium Chloride; D009538:Nicotine; D000109:Acetylcholine; D002118:Calcium